drugset
drugset / Trial / NCT03649555

Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls

NCT03649555 ↗

Phase 1 Completed 5 enrolled Stanford University
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.

Timeline

Start
2019-02-01
Primary completion
2020-03-03
Completion
2021-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FTC-146 Diagnostic / imaging agent 5 mbq Intravenous

Indications

No indication recorded.